BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang H, Guo D, Xu Y, Zhu M, Yao C, Chen C, Jia W. Comparison of Different Liver Test Thresholds for Drug-Induced Liver Injury: Updated RUCAM versus Other Methods. Front Pharmacol 2019;10:816. [PMID: 31379581 DOI: 10.3389/fphar.2019.00816] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Machado TR, Faro LV, Mello ALDN, Silva DDO, Abrahim-vieira BDA, Rodrigues CR, Silva RHS, Junior CSV, Sola-penna M, Boechat FDC, de Souza MC, Zancan P, de Souza MCB, de Souza AM. 4-oxoquinoline-3-carboxamide acyclonucleoside phosphonates hybrids: human MCF-7 breast cancer cell death induction by oxidative stress-promoting and in silico ADMET studies. Journal of Molecular Structure 2022. [DOI: 10.1016/j.molstruc.2022.134542] [Reference Citation Analysis]
2 Rodríguez A, García-garcía I, Martínez de Soto L, Gómez López De Las Huertas A, Borobia AM, González-torbay A, Akatbach-bousaid I, González-muñoz M, Ramírez E. Utility of Lymphocyte Transformation Test for Assisting Updated Roussel Uclaf Causality Assessment Method in Drug-Induced Liver Injury: A Case-Control Study. Front Pharmacol 2022;13:819589. [DOI: 10.3389/fphar.2022.819589] [Reference Citation Analysis]
3 Teschke R, Xuan TD. Suspected herb induced liver injury by green tea extracts: Critical review and case analysis applying RUCAM for causality assessment.Japanese J Gastroenterol Hepatol. 2019;6:1-16. [DOI: 10.21037/tgh-20-149] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
4 Kong X, Guo D, Liu S, Zhu Y, Yu C. Incidence, characteristics and risk factors for drug-induced liver injury in hospitalized patients: A matched case-control study. Br J Clin Pharmacol 2021. [PMID: 33948989 DOI: 10.1111/bcp.14847] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
5 Teschke R, Danan G. Idiosyncratic Drug-Induced Liver Injury (DILI) and Herb-Induced Liver Injury (HILI): Diagnostic Algorithm Based on the Quantitative Roussel Uclaf Causality Assessment Method (RUCAM). Diagnostics (Basel) 2021;11:458. [PMID: 33800917 DOI: 10.3390/diagnostics11030458] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
6 Wan M, Xu H, Li D, Wang L, Li X. Accuracy of gamma-glutamyl transpeptidase-to-platelet ratio (GPR), red cell distribution width (RDW), aspartate aminotransferase-to-platelet ratio index (APRI), and the fibrosis-4 index (FIB4) compared with liver biopsy in patients with drug-induced liver injury (DILI). Medicine (Baltimore) 2021;100:e24723. [PMID: 33578617 DOI: 10.1097/MD.0000000000024723] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Teschke R, Danan G. Worldwide Use of RUCAM for Causality Assessment in 81,856 Idiosyncratic DILI and 14,029 HILI Cases Published 1993-Mid 2020: A Comprehensive Analysis. Medicines (Basel) 2020;7:E62. [PMID: 33003400 DOI: 10.3390/medicines7100062] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 11.7] [Reference Citation Analysis]
8 Teschke R, Zhu Y, Jing J. Herb-induced Liver Injury in Asia and Current Role of RUCAM for Causality Assessment in 11,160 Published Cases. J Clin Transl Hepatol 2020;8:200-14. [PMID: 32832401 DOI: 10.14218/JCTH.2020.00009] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
9 Sandhu N, Navarro V. Drug-Induced Liver Injury in GI Practice. Hepatol Commun. 2020;4:631-645. [PMID: 32363315 DOI: 10.1002/hep4.1503] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 8.3] [Reference Citation Analysis]